When oxidative stress goes unchecked, it can lead to cellular fatigue in the kidneys
Details As the publication indicates, previous studies have shown that "people receiving a standard weekly injection of the drug "Wegovy", which contains the active ingredient semaglutide, typically lose about 15% of their body weight within a year in combination with exercise and a healthy diet." The drug works by mimicking the action of the hormone glucagon-like peptide-1, or GLP1, which causes delayed gastric emptying and affects the brain, reducing appetite
Taking it every 5 days one week and every 9 days the next creates uneven blood levels that reduce efficacy and increase side effects
- Sau 1 thng s dng vin ung trng da
J Dent 2013;41:56980
With both drugs inducing a magnitude of weight loss not seen previously with pharmacotherapy, the field is now shifting to further drug development as well as discovering whether semaglutide and tirzepatide can improve a range of obesity-related comorbidities, she said